Skip to main content
Log in

Evidence for beneficial effects of antidepressants on suicidality in depressive patients

A systematic review

  • REVIEW
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

The role of antidepressants in suicide prevention is a major public health question, given the high prevalence of both depression and depression-related suicidality. Therefore all means available should be utilised to clarify the influence of antidepressants on suicidality. This paper gives a comprehensive overview of the positive effects of antidepressants on suicidality. In the first section, principal methodological issues related to suicidology in general as well as to clinical and epidemiological studies that investigate the influence of antidepressants on suicidality are discussed. In the second section, the results of controlled clinical studies on the efficacy of antidepressants in suicidality are presented. The third section reports on the results of other types of studies, especially epidemiological studies. Altogether, there seems to be reasonable evidence from different research approaches that antidepressants are able to reduce suicidal ideation and also suicidal behaviour in depressive patients. While the evidence for the beneficial effect on suicidal ideation comes from randomised control group studies, some of which used a placebo arm, the evidence for the prophylactic effect on suicidal behaviour, especially suicide, was primarily obtained from well-designed epidemiological studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bradvik L (2002) The occurrence of suicide in severe depression related to the months of the year and the days of the week. Eur Arch Psychiatry Clin Neurosci 252:28–32

    PubMed  Google Scholar 

  2. Bradvik L, Berglund M (2000) Suidical ideation in severe depression. Eur Arch Psychiatry Clin Neurosci 250:139–143

    Article  PubMed  CAS  Google Scholar 

  3. Bradvik L, Berglund M (2004) Suicide in severe depression related to treatment: depressive characteristics and rate of antidepressant overdose. Eur Arch Psychiatry Clin Neurosci 255:245–250

    Article  PubMed  Google Scholar 

  4. Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62:165–172

    Article  PubMed  CAS  Google Scholar 

  5. Isometsa ET, Henriksson MM, Aro HM, Heikkinen ME, Kuoppasalmi KI, Lonnqvist JK (1994) Suicide in major depression. Am J Psychiatry 151:530–536

    CAS  Google Scholar 

  6. Moller HJ (2003) Suicide, suicidality and suicide prevention in affective disorders. Acta Psychiatr Scand 108(Suppl. 418):73–80

    Article  Google Scholar 

  7. Baldwin D, Bullock T, Montgomery D, Montgomery S (1991) 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour. Int Clin Psychopharmacol 6(Suppl. 3):49–55

    Article  PubMed  Google Scholar 

  8. Isacsson G (2000) Suicide prevention–a medical breakthrough? Acta Psychiatr Scand 102:113–117

    Article  PubMed  CAS  Google Scholar 

  9. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330:396

    Article  PubMed  CAS  Google Scholar 

  10. Möller HJ (1992) Antidepressants – do they decrease or increase suicidality? Pharmacopsychiatry 25:249–253

    PubMed  Google Scholar 

  11. Teicher MH, Glod CA, Cole JO (1993) Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 8:186–212

    PubMed  CAS  Google Scholar 

  12. Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ (2004) Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry 65:1456–1462

    Article  PubMed  Google Scholar 

  13. Möller HJ (2006) Is there evidence for negative effects of antidepressants on suicidality in depressive patients? Eur Arch Psychiatry Clin Neurosci In Press

  14. Kurz A, Möller HJ, Baindl G, Burk F, Torhorst A, Wachtler C, Lauter H (1987) Classification of parasuicide by cluster analysis. Types of suicidal behaviour, therapeutic and prognostic implications. Br J Psychiatry 150:520–525

    Article  PubMed  CAS  Google Scholar 

  15. Kurz A, Möller HJ, Torhorst A, Lauter H (1988) Validation of six risk scales for suicide attempters. In: Möller HJ, Schmidtke A, Welz R (eds) Current issues of suicidology. Springer, Berlin, Heidelberg, New York, pp 174–178

    Google Scholar 

  16. Lejoyeux M, Leon E, Rouillon F (1994) Prevalence and risk factors of suicide and attempted suicide. Encephale 20:495–503

    PubMed  CAS  Google Scholar 

  17. Möller HJ (1990) Suicide risk and treatment problems in patients who have attempted suicide. In: Lester D (eds) Current concepts of suicide. Charles Press, Philadelphia, pp 168–181

    Google Scholar 

  18. Brown GK, Beck AT, Steer RA, Grisham JR (2000) Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol 68:371–377

    Article  PubMed  CAS  Google Scholar 

  19. Moscicki EK (1999) Epidemiology of suicide. In: Jacobs D (eds) The Harvard Medical School guide to suicide assessment and intervention. Jossey-Bass, San Francisco, pp 40–51

    Google Scholar 

  20. ACNP (1993) Suicidal behavior and psychotropic medication. Accepted as a consensus statement by the ACNP Council, March 2, 1992. Neuropsychopharmacology 8:177–183

    Google Scholar 

  21. Montgomery S, Cronholm B, Asberg M, Montgomery DB (1978) Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline. Br J Clin Pharmacol 5 (Suppl. 1):77S–80S

    PubMed  Google Scholar 

  22. Asberg M, Nordström P (1988) Biological correlates of suicidal behaviour. In: Möller HJ, Schmidtke A, Welz R (eds) Current issues of suicidology. Springer, Berlin, Heidelberg, New York, pp 221–241

    Google Scholar 

  23. Traskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636

    PubMed  CAS  Google Scholar 

  24. Rujescu D, Giegling I, Sato T, Möller HJ (2001) A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatric Genet 11:169–172

    Article  CAS  Google Scholar 

  25. Rujescu D, Giegling I, Sato T, Hartmann AM, Moller HJ (2003) Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis. Biol Psychiatry 54:465–473

    Article  CAS  Google Scholar 

  26. Rujescu D, Giegling I, Sato T, Moller HJ (2003) Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior. Am J Med Genet 116B:69–71

    Article  Google Scholar 

  27. Montgomery SA, McAuley R, Rani SJ, Roy D, Montgomery DB (1981) A double blind comparison of zimelidine and amitriptyline in endogenous depression. Acta Psychiatr Scand Suppl 290:314–327

    PubMed  CAS  Google Scholar 

  28. de Wilde J, Mertens C, Overo KF, Petersen HE (1985) Citalopram versus mianserin. A controlled, double-blind trial in depressed patients. Acta Psychiatr Scand 72:89–96

    PubMed  Google Scholar 

  29. Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773–782

    PubMed  CAS  Google Scholar 

  30. Amin MM, Anath JV, Coleman BS, Darcourt G, Farkas T, Goldstein BJ, Lapierre YD, Paykel ES, Wakelin JS (1984) Fluvoxamine antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol 7(Suppl. 1):580–581

    Google Scholar 

  31. Wakelin JS (1988) The role of serotonin in depression and suicide: do serotonin reuptake inhibitors provide a key? In: Mendlewitcz JH, van Praag M (eds) Advances in biological psychiatry. Karger, Basel, pp 70–80

    Google Scholar 

  32. Muijen M, Roy D, Silverstone T, Mehmet A, Christie M (1988) A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatr Scand 78:384–390

    PubMed  CAS  Google Scholar 

  33. Möller HJ, Steinmeyer EM (1994) Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. Eur Neuropsychopharmacol 4:55–59

    Article  PubMed  Google Scholar 

  34. Beasley CM Jr., Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr., Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 303:685–692

    Article  PubMed  Google Scholar 

  35. Montgomery SA (1992) The advantages of paroxetine in different subgroups of depression. Int Clin Psychopharmacol 6(Suppl. 4):91–100

    PubMed  Google Scholar 

  36. Lopez-Ibor JJ (1993) Reduced suicidality with paroxetine. Eur Psychiatry 8(Suppl. 1):17s–19s

    Google Scholar 

  37. Pedersen AG (2005) Escitalopram and suicidality in adult depression and anxiety. Int Clin Psychopharmacol 20:139–143

    Article  PubMed  Google Scholar 

  38. Khan A, Warner HA, Brown WA (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 57:311–317

    Article  PubMed  CAS  Google Scholar 

  39. Khan A, Khan SR, Leventhal RM, Brown WA (2001) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. Int J Neuropsychopharmacol 4:113–118

    Article  PubMed  CAS  Google Scholar 

  40. Khan A, Khan S, Kolts R, Brown WA (2003) Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 160:790–792

    Article  PubMed  Google Scholar 

  41. Storosum JG, van Zwieten BJ, van den BW, Gersons BP, Broekmans AW (2001) Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 158:1271–1275

    Article  PubMed  CAS  Google Scholar 

  42. Gunnell D, Saperia J, Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. BMJ 330:385

    Article  PubMed  CAS  Google Scholar 

  43. Carlsten A, Waern M, Ekedahl A, Ranstam J (2001) Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 10:525–530

    Article  PubMed  CAS  Google Scholar 

  44. Rihmer Z (2001) Can better recognition and treatment of depression reduce suicide rates? A brief review. Eur Psychiatry 16:406–409

    Article  PubMed  CAS  Google Scholar 

  45. Rihmer Z, Appleby L, Rihmer A, Belso N (2000) Decreasing suicide in Hungary. Br J Psychiatry 177:84

    Article  PubMed  CAS  Google Scholar 

  46. Rihmer Z, Rutz W, Pihlgren H, Pestality P (1998) Decreasing tendency of seasonality in suicide may indicate lowering rate of depressive suicides in the population. Psychiatry Res 81:233–240

    Article  PubMed  CAS  Google Scholar 

  47. Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P (2003) Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ 326:1008

    Article  PubMed  Google Scholar 

  48. Olfson M, Shaffer D, Marcus SC, Greenberg T (2003) Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978–982

    Article  PubMed  Google Scholar 

  49. FDA Public Health Advisory (2004) Suicidality in children and adolescents being treated with antidepressant medications. www. fda. gov/cder/drug/antidepressants/SSRIPHA200410

  50. Kelly CB, Ansari T, Rafferty T, Stevenson M (2003) Antidepressant prescribing and suicide rate in Northern Ireland. Eur Psychiatry 18:325–328

    Article  PubMed  Google Scholar 

  51. Barbui C, Campomori A, D’Avanzo B, Negri E, Garattini S (1999) Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol 34:152–156

    Article  PubMed  CAS  Google Scholar 

  52. Helgason T, Tomasson H, Zoega T (2004) Antidepressants and public health in Iceland. Time series analysis of national data. Br J Psychiatry 184:157–162

    Article  PubMed  Google Scholar 

  53. Rihmer Z (2004) Decreasing national suicide rates–fact or fiction? World J Biol Psychiatry 5:55–56

    Article  PubMed  Google Scholar 

  54. Van Praag HM (2003) A stubborn behaviour: the failure of antidepressants to reduce suicide rates. World J Biol Psychiatry 4:184–191

    Article  PubMed  Google Scholar 

  55. Rihmer Z, Belso N, Kalmar S (2001) Antidepressants and suicide prevention in Hungery. Acta Psychiatr Scand 103:238–239

    Article  PubMed  CAS  Google Scholar 

  56. Isacsson G, Bergman U, Rich CL (1996) Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 41:1–8

    Article  PubMed  CAS  Google Scholar 

  57. Isacsson G, Boethius G, Bergman U (1992) Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr Scand 85:444–448

    PubMed  CAS  Google Scholar 

  58. Isacsson G, Holmgren P, Druid H, Bergman U (1997) The utilization of antidepressants – a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992–1994. Acta Psychiatr Scand 96:94–100

    PubMed  CAS  Google Scholar 

  59. Isometsa E, Henriksson M, Heikkinen M, Aro H, Lonnqvist J (1994) Suicide and the use of antidepressants. Drug treatment of depression is inadequate. BMJ 308:915

    CAS  Google Scholar 

  60. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ (1999) Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry 156:190–194

    PubMed  CAS  Google Scholar 

  61. Angst J, Gamma A, Gastpar M, Lepine JP, Mendlewicz J, Tylee A (2002) Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci 252:201–209

    Article  CAS  Google Scholar 

  62. Lepine JP, Gastpar M, Mendlewicz J, Tylee A (1997) Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12:19–29

    PubMed  CAS  Google Scholar 

  63. Tylee A, Gastpar M, Lepine JP, Mendlewicz J (1999) DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 14:139–151

    CAS  Google Scholar 

  64. Tylee A, Gastpar M, Lepine JP, Mendlewicz J (1999) Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) survey. DEPRES Steering Committee. Int Clin Psychopharmacol 14:153–165

    CAS  Google Scholar 

  65. Cheng AT (1995) Mental illness and suicide. A case–control study in east Taiwan. Arch Gen Psychiatry 52:594–603

    PubMed  CAS  Google Scholar 

  66. Isacsson G, Bergman U, Rich CL (1994) Antidepressants, depression and suicide: an analysis of the San Diego study. J Affect Disord 32:277–286

    Article  CAS  Google Scholar 

  67. Isacsson G, Holmgren P, Wasserman D, Bergman U (1994) Use of antidepressants among people committing suicide in Sweden. BMJ 308:506–509

    CAS  Google Scholar 

  68. Rich CL, Isacsson G (1997) Suicide and antidepressants in south Alabama: evidence for improved treatment of depression. J Affect Disord 45:135–142

    Article  PubMed  CAS  Google Scholar 

  69. Isacsson G, Wasserman D, Bergman U (1995) Self-poisonings with antidepressants and other psychotropics in an urban area of Sweden. Ann Clin Psychiatry 7:113–118

    Article  PubMed  CAS  Google Scholar 

  70. Kurz A, Möller HJ, Burk F, Torhorst A, Wachtler C, Lauter H (1985) Determination of treatment disposal for parasuicide patients in a German university hospital. Soc Psychiatry 20:145–151

    Article  PubMed  CAS  Google Scholar 

  71. Wasserman D, Persson ML (1993) Suicide. Lancet 342:745

    Article  PubMed  CAS  Google Scholar 

  72. Priest RG (1994) Improving the management and knowledge of depression. Br J Psychiatry 164:285–287

    Article  PubMed  CAS  Google Scholar 

  73. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, Hegerl U, Lonnqvist J, Malone K, Marusic A, et al. (2005) Suicide prevention strategies: a systematic review. JAMA 294:2064–2074

    Article  PubMed  CAS  Google Scholar 

  74. Rutz W, von Knorring L, Walinder J (1992) Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatr Scand 85:83–88

    PubMed  CAS  Google Scholar 

  75. Paykel ES, Tylee A, Wright A, Priest RG, Rix S, Hart D (1997) The Defeat Depression Campaign: psychiatry in the public arena. Am J Psychiatry 154:59–65

    PubMed  CAS  Google Scholar 

  76. Paykel ES (2001) Impact of public and general practice education in depression: evaluation of the defeat depression campaign. Psychiatria Fennica 32(Suppl. 2):51–61

    Google Scholar 

  77. Rix S, Paykel ES, Lelliott P, Tylee A, Freeling P, Gask L, Hart D (1999) Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract 49:99–102

    PubMed  CAS  Google Scholar 

  78. Paykel ES, Hart D, Priest RG (1998) Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psychiatry 173:519–522

    PubMed  CAS  Google Scholar 

  79. Althaus D, Niklewski G, Pfeiffer-Gerschel T, Schmidtke A, Hegerl U (2005) Vom “Nürnberger Bündnis gegen Depression” zur “European Alliance against Depression”. Modelle zur Optimierung der Versorgung depressiver Patienten. Nervenheilkunde 24:402–407

    Google Scholar 

  80. Hegerl U, Althaus D, Stefanek J (2003) Public attitudes towards treatment of depression: effects of an information campaign. Pharmacopsychiatry 36:288–291

    Article  PubMed  CAS  Google Scholar 

  81. Henkel V, Mergl R, Kohnen R, Maier W, Moller HJ, Hegerl U (2003) Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ 326:200–201

    Article  PubMed  Google Scholar 

  82. Angst F, Stassen HH, Clayton PJ, Angst J (2002) Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord 68:167–181

    Article  CAS  Google Scholar 

  83. Moller HJ, Grunze H, Broich K (2006) Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci 256:1–16

    Article  PubMed  Google Scholar 

  84. Yerevanian BI, Koek RJ, Feusner JD, Hwang S, Mintz J (2004) Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatr Scand 110:452–458

    Article  PubMed  CAS  Google Scholar 

  85. Cipriani A, Pretty H, Hawton K, Geddes JR (2005) Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805–1819

    Article  PubMed  Google Scholar 

  86. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord 23:1–7

    Article  PubMed  CAS  Google Scholar 

  87. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290:1467–1473

    Article  PubMed  CAS  Google Scholar 

  88. Müller-Oerlinghausen B (1989) Pharmakotherapie pathologischen aggressiven und autoaggressiven Verhaltens. In: Pöldinger W, Wagner W (eds) Aggression, Selbstaggression, Familie und Gesellschaft. Springer, Berlin, Heidelberg, New York, pp 121–134

    Google Scholar 

  89. Tondo L, Hennen J, Baldessarini RJ (2001) Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 104:163–172

    Article  PubMed  CAS  Google Scholar 

  90. Schrauzer GN, Shrestha KP (1990) Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions. Biol Trace Elem Res 25:105–113

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans-Jürgen Möller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möller, HJ. Evidence for beneficial effects of antidepressants on suicidality in depressive patients. Eur Arch Psychiatry Clin Neurosci 256, 329–343 (2006). https://doi.org/10.1007/s00406-006-0650-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-006-0650-x

Key words

Navigation